Alan Knuckman of Bulls-Eye Option spoke on Bloomberg Markets about a bullish options strategy in Valeant Pharmaceuticals Intl Inc VRX.
He wants to sell the February 13 put in Valeant Pharmaceuticals for $0.65. The trade breaks even at $12.35 or approximately 9 percent below the current market price. Knuckman explained that he's using a cash secured naked put as a way to get in the stock at a lower price level or to get paid not to enter the position.
Knuckman added that the trade offers a chance to get in Valeant Pharmaceuticals at a price level not seen since 2008.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.